Ingestible sensors are emerging as a promising frontier in gastroenterology, offering a minimally invasive way to monitor the gastrointestinal (GI) tract in real time. Instead of relying solely on endoscopy or colonoscopy—which are costly, invasive, and often avoided by patients—swallowable devices can capture biochemical signals such as gases and redox balance as they pass through the gut, opening new possibilities for earlier diagnosis, improved disease monitoring, and targeted drug delivery. In the long run, researchers even envision “electronic food” made from edible electronic components that could diagnose disease and release therapies precisely where they are needed.
What are some of these these technologies? The Economist‘s recent article (“Tomorrow’s medical sensors might come served with dinner“) provides some examples:
GISMO (Gastrointestinal Smart Module)
An edible Tic Tac–sized capsule that travels the length of the gut, measures redox balance every 20 seconds, and wirelessly transmits data to a belt‑worn receiver, with current testing in patients with ulcerative colitis and colorectal cancer.PillCam
A swallowable camera capsule, now owned by Medtronic, that has been used in millions of patients to image the GI tract as a less invasive alternative to traditional endoscopy.Hydrogen sulphide sensor capsule (University of Maryland, 2023)
A capsule using a gold electrode coated in Nafion to detect hydrogen sulphide in real time, targeting signals associated with inflammatory bowel disease and Helicobacter pylori infection.Optoelectronic oxygen/ammonia capsule (USC, 2024)
An ingestible pill with optoelectronic sensors for oxygen and ammonia that, combined with neural‑network algorithms, can map gas concentrations along the GI tract with millimetre‑scale spatial resolution in preclinical studies.Atmo Biosciences fermentation‑gas capsule
A capsule in clinical development that measures fermentation gases to diagnose small intestinal bacterial overgrowth, with sensitivity reported to far exceed standard breath testing.MIT jet‑propulsion drug‑delivery capsule
An ingestible device inspired by cephalopod jet propulsion that senses internal conditions and can pump drugs directly into the wall of the digestive tract at targeted sites.MIT mRNA and electroceutical platform (ARPA‑H–funded)
A multi‑year programme to develop ingestible devices for oral delivery of mRNA therapies and electroceuticals that modulate hormonal and neural signalling networks.Edible rechargeable battery (Italian Institute of Technology, ELFO project)
A proof‑of‑concept edible battery made from food‑derived materials such as riboflavin, quercetin, activated charcoal, seaweed, beeswax, and food‑grade gold contacts, capable of powering low‑energy electronics for short periods.Fully edible transistor (Italian Institute of Technology)
An edible transistor built using copper phthalocyanine, a pigment found in toothpaste, as the semiconductor, illustrating a path toward edible logic circuits even though performance is far behind conventional chips.
Despite the excitement around ingestible sensors and edible electronics, several practical challenges remain. Power is a central constraint: most current capsules still depend on conventional silver‑oxide batteries that limit miniaturization, create electronic waste that must exit the body, and are not ideal for long‑term or large‑scale monitoring. Edible batteries and semiconductors exist, but they are energy‑poor, relatively unstable, and far less capable than traditional components. Many advanced devices also still contain non‑edible elements, so they are not yet truly “food‑grade” throughout, raising safety and regulatory questions. Finally, retrieval remains an operational issue: most sensors must be recovered in stool, which is logistically inconvenient and may affect adherence in real‑world use. Taken together, these constraints highlight the gap between early‑stage technological feasibility and scalable, cost‑effective deployment of ingestible sensors in routine clinical practice.
